
Isabel Lee
Bloomberg News cross-asset reporter who provides market commentary and analysis on corporate earnings and stock movements.
Top 5 podcasts with Isabel Lee
Ranked by the Snipd community

15 snips
Feb 4, 2026 • 6min
Google Rises; Arm, Qualcomm Fall After Earnings
Isabel Lee, Bloomberg cross-asset reporter with tech and AI expertise. She breaks down Arm's weak AI-linked revenue forecast. She discusses Alphabet’s strong revenue and aggressive capex to build AI infrastructure. She covers Qualcomm’s cautious revenue outlook amid component and handset concerns.

Apr 1, 2026 • 5min
Nike Slumps, Intel Jumps, Tesla Gains
Isabel Lee, Bloomberg cross-asset reporter who covers market-moving earnings and stock moves. She breaks down Nike’s sharp revenue warning and share slide. She explains Intel’s $14.2B Ireland plant deal and what it means for the turnaround. She outlines Tesla’s softer delivery trend and its strategic pivot to AI, autonomy and robotics.

Feb 11, 2026 • 5min
Cisco Falls After Earnings, McDonald's Sees Sales Growth, Zillow Tumbles
Isabel Lee, a Bloomberg cross-asset reporter who covers market-moving companies, breaks down big movers in the market. She walks through Cisco’s AI-driven revenue gains and margin worries. She highlights McDonald’s surprisingly strong U.S. sales powered by value deals and promos. She also covers Zillow’s profit downgrades and the stock’s sharp decline.

Feb 2, 2026 • 6min
Disney Falls, Bed Bath & Beyond Up on Deal
Isabel Lee, Bloomberg cross-asset reporter who covers market movers, breaks down big stock swings. She explains Bed Bath & Beyond’s deal to build a tokenized real-estate finance platform. She covers Verra Mobility’s tumble after policy news and Disney’s weak growth outlook and leadership uncertainty. Short, sharp market color on today’s biggest movers.

Dec 31, 2025 • 7min
Nike, Trump Media End Day Higher; Corcept Plunges
Isabel Lee, a Bloomberg News Cross Asset reporter, dives into today's market movers. Nike's shares rose after CEO Elliott Hill and Tim Cook made substantial stock purchases, signaling strong insider confidence. Trump Media's stock climbed over 5% following their announcement of a new cryptocurrency for shareholders. In stark contrast, Corcept's shares plummeted after the FDA rejected its high blood pressure drug due to insufficient evidence of effectiveness. Join Isabel as she unpacks these intriguing market dynamics!


